News Hub

Real-time financial, economic, and global news with market-focused context and analysis.

Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.

  • BofA released a Fed-watching primer detailing the Fed's mandate, FOMC votes, new communication, policy tools, and balance-sheet metrics.
  • Analysts recommend a defensive short on Salesforce, citing metered AI monetization and broken technical momentum, target $130.
  • IREN pivoted to AI-first data centers with Nvidia and Dell contracts and expanded European capacity, prompting bullish trade setups.
  • A buy-write strategy on ITWO could yield about 7.5% annually while retaining upside optionality to roughly $50.
  • Analysts emphasize tactical, mid-term swing trades across AI, cloud, and yield products amid ongoing Fed policy monitoring.

Latest Articles

Crinetics Presents Long Term Data at ENDO 2026 Confirming PALSONIFY™ (paltusotine) Provides Durable, Consistent Acromegaly Control

Crinetics Presents Long Term Data at ENDO 2026 Confirming PALSONIFY™ (paltusotine) Provides Durable, Consistent Acromegaly Control

Crinetics Pharmaceuticals presented up to two years of data from PATHFNDR-1 and PATHFNDR-2 open-label extension studies showing that PALSONIFY (paltusotine), an oral somatostatin receptor agonist, maintains stable IGF-1 levels, controls acromegaly symptoms, and stabilizes or reduces pituitary tumor volume. The data confirmed durable disease control…

Positioning for a Strategic Pivot at Headwater Exploration

Positioning for a Strategic Pivot at Headwater Exploration

Headwater Exploration (CDDRF) is trading around short-term moving averages as short interest unwinds. Management hinted at higher capex and faster growth in prior guidance; an earnings-driven strategy update could spark a directional move. We present a mid-term long trade with entry at $9.26, a $12.00 target and an $8.00 stop — sized for a medium-r…

SpaceX's Launch Cost Breakthrough Rewrites Its Market Prospects

SpaceX's Launch Cost Breakthrough Rewrites Its Market Prospects

Wolfe Research has initiated coverage on SpaceX (SPCX) with a $175 price target after the company's IPO, arguing that reusability-driven reductions in internal launch costs and a Starlink connectivity inflection point create a durable competitive advantage and substantial earnings upside by 2030. The firm projects steep revenue growth and margin ex…

Carney Returns to Ancestors' Village in Ireland Ahead of G7 Visit

Carney Returns to Ancestors' Village in Ireland Ahead of G7 Visit

Canadian Prime Minister Mark Carney traveled to Aughagower in western Ireland to trace his family roots, meet distant relatives and participate in local religious and commemorative rituals. On a trip en route to the G7 meeting in France, he used public appearances in Dublin to urge deeper cooperation between Canada, Ireland and Europe as the post-C…

Anger at G7 Sparks Damage in Geneva as Protesters Burn Tesla and Smash Bank Windows

Anger at G7 Sparks Damage in Geneva as Protesters Burn Tesla and Smash Bank Windows

Thousands marched in Geneva to protest the Group of Seven summit scheduled across the border, expressing opposition to concentrated political and economic power. While the demonstration was mostly peaceful, some participants set fire to a Tesla and damaged a bank, prompting a heavy police presence and preemptive security measures by local businesse…

Deadly Strikes in Gaza Kill Six as Mediators Push to Revive Truce Plan

Deadly Strikes in Gaza Kill Six as Mediators Push to Revive Truce Plan

At least six Palestinians were killed in Gaza in separate incidents of strikes and gunfire, health officials said, as mediators concluded week-long discussions aimed at implementing the second phase of a U.S.-brokered ceasefire plan. The violence coincided with diplomatic efforts to secure disarmament and an Israeli withdrawal outlined in a 15-poin…

BofA: Further 3% S&P 500 Slide Could Prompt Additional Systematic Selling

BofA: Further 3% S&P 500 Slide Could Prompt Additional Systematic Selling

Bank of America analysts say Commodity Trading Advisors (CTAs) have pared equity longs after recent market weakness but retain net long exposure. Their models suggest that a further roughly 3% fall in the S&P 500 - and a roughly 5% fall in the NASDAQ-100 - could trigger another wave of systematic selling, particularly as stop-loss frameworks bite. …

Celldex Presents Long-Term Barzolvolimab Results Demonstrating Sustained Off-Treatment Improvement in Angioedema in Patients with CSU at the European Academy of Allergy and Clinical Immunology Annual Meeting

Celldex Presents Long-Term Barzolvolimab Results Demonstrating Sustained Off-Treatment Improvement in Angioedema in Patients with CSU at the European Academy of Allergy and Clinical Immunology Annual Meeting

Celldex Therapeutics presented long-term Phase 2 data demonstrating that barzolvolimab treatment yields rapid, significant, and durable improvements in angioedema symptoms among patients with moderate to severe chronic spontaneous urticaria (CSU). Up to 64% of patients remained angioedema-free seven months post-treatment, indicating potential disea…

Upstream Bio Presents New Responder Analyses Demonstrating Clinically Meaningful Improvements in CRSwNP in Significant Majority of Participants Treated with Verekitug in the Phase 2 VIBRANT Trial at EAACI 2026

Upstream Bio Presents New Responder Analyses Demonstrating Clinically Meaningful Improvements in CRSwNP in Significant Majority of Participants Treated with Verekitug in the Phase 2 VIBRANT Trial at EAACI 2026

Upstream Bio presented new responder analyses from its Phase 2 VIBRANT trial demonstrating that Verekitug, a TSLP receptor antagonist administered every three months, achieved clinically meaningful improvements in nasal polyp score and multiple key symptoms in a significant majority of patients with chronic rhinosinusitis with nasal polyps (CRSwNP)…

Mineralys Therapeutics Presents Late-Breaking Data on Lorundrostat and Heart Failure Risk Biomarkers at The Endocrine Society Annual Meeting (ENDO 2026)

Mineralys Therapeutics Presents Late-Breaking Data on Lorundrostat and Heart Failure Risk Biomarkers at The Endocrine Society Annual Meeting (ENDO 2026)

Mineralys Therapeutics presented post hoc proteomic analysis data indicating that lorundrostat, an investigational aldosterone synthase inhibitor, significantly reduces biomarkers linked to heart failure risk in patients with uncontrolled hypertension. These findings support lorundrostat's therapeutic potential and coincide with ongoing FDA review.…

Buying Reddit's Core Business, Not the Hype - A Mid-Term Trade

Buying Reddit's Core Business, Not the Hype - A Mid-Term Trade

Reddit is trading well below its 52-week high despite strong top-line growth and exceptional profitability in recent quarters. This trade idea argues the market is focused on headline threats and sector rotation while missing the durability of Reddit's advertising and AI-data revenue streams. Entry at current levels, modest stop, and a mid-term tar…

New Fed Leadership Adds Uncertainty to Cooling U.S. Equity Rally

New Fed Leadership Adds Uncertainty to Cooling U.S. Equity Rally

The U.S. stock market has shown increasing volatility after a strong spring rally, and investors are focused on the Federal Reserve's upcoming policy meeting - the first under Chair Kevin Warsh. With major indexes retreating from recent highs, elevated volatility readings and fresh inflation and jobs data, market participants are parsing Fed commun…

SpaceX IPO Propels Elon Musk Past $1 Trillion Net Worth

SpaceX IPO Propels Elon Musk Past $1 Trillion Net Worth

SpaceX's initial public offering raised a record $75 billion and saw strong first-day trading, pushing Elon Musk's personal net worth to an estimated $1.1 trillion. The windfall concentrates a large portion of his wealth in SpaceX equity, intensifying debate over governance, political involvement and the risks tied to valuation assumptions for long…

Saudi Stocks Finish Higher as Transport, Cement and Tourism Lift TASI

Saudi Stocks Finish Higher as Transport, Cement and Tourism Lift TASI

Saudi Arabia's equity market closed higher, with the Tadawul All Share rising 0.57% as advances in the Transport, Cement and Hotels & Tourism sectors powered the session. Market breadth favored gainers, while several individual large-cap names recorded notable moves. Commodities and currency pairs moved notably alongside equities.

Snap’s Growth Thesis Is Foggy — A Mid-Term Short Setup

Snap’s Growth Thesis Is Foggy — A Mid-Term Short Setup

Snap Inc. trades at $5.26 with a market cap near $8.7B. The company generates free cash flow but remains unprofitable on the income statement, shows modest revenue growth versus larger peers, and carries leverage and regulatory headwinds. Technicals and rising short interest support a near-term bearish bias. This trade idea lays out a mid-term shor…

Three factors behind Europe’s lagging equity performance

Three factors behind Europe’s lagging equity performance

European equities have underperformed global peers by about 7% since the Middle East conflict began. Goldman Sachs identifies three principal drivers - energy uncertainty, rising interest rates and limited exposure to the AI-led technology rally - that together help explain the region’s relative weakness. The bank highlights how Europe's status as …

Park Aerospace: Two Engines of Growth, One Clear Long-Term Trade

Park Aerospace: Two Engines of Growth, One Clear Long-Term Trade

Park Aerospace (PKE) has quietly built a double juggernaut: high-value advanced composites for aerospace and a shareholder-friendly cash dividend streak that spans four decades. The company is small-cap ($744M market cap) but growing: recent quarters showed ~20% sales growth and earnings acceleration, technicals are constructive, and capital alloca…

Soitec Poised to Rebound: Buy for a Multi-Month Recovery

Soitec Poised to Rebound: Buy for a Multi-Month Recovery

Soitec (SOI) looks positioned for a durable recovery as demand for specialty substrates from data centers, 5G/AI accelerators, and automotive chips strengthens. We recommend a long trade with a clear entry at $72.50, a stop at $60.00 and a primary target at $95.00 over a multi-month horizon (180 trading days).